Pharmaceutical companies by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Takeda Pharmaceutical has the lowest figure of the 61 pharmaceutical companies ranked by short interest, at 0.10%, followed by AstraZeneca (0.20%) and Novartis (0.24%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- Takeda Pharmaceutical0.10%
- Median
- 5.47%
- Combined market value
- SEK 51.51T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Takeda PharmaceuticalTAK · Health Care | 0.10% | SEK 692.6B | SEK 216.78 | 1.46% down | 54% up | ||
| 2 | AstraZenecaAZN · Health Care | 0.20% | SEK 2.82T | SEK 1,817.13 | 1.93% down | 2% up | ||
| 3 | NovartisNVS · Health Care | 0.24% | SEK 2.98T | SEK 1,579.45 | 2.36% down | 25% up | ||
| 4 | SanofiSNY · Health Care | 0.51% | SEK 1.15T | SEK 479.98 | 0.66% down | 4% down | ||
| 5 | Johnson & JohnsonJNJ · Health Care | 0.71% | SEK 6.7T | SEK 2,784.35 | 1.72% down | 38% up | ||
| 6 | GSKGSK · Health Care | 0.81% | SEK 990.3B | SEK 494.05 | 1.30% down | 6% up | ||
| 7 | Eli LillyLLY · Health Care | 0.81% | SEK 12.55T | SEK 14,091.80 | 2.07% down | 35% up | ||
| 8 | Novo NordiskNVO · Health Care | 0.87% | SEK 1.77T | SEK 401.09 | 3.06% down | 17% down | ||
| 9 | GrifolsGRFS · Health Care | 0.88% | SEK 58.4B | SEK 85.75 | 2.26% down | 1% up | ||
| 10 | AbbVieABBV · Health Care | 0.89% | SEK 5.14T | SEK 2,909.99 | 2.24% down | 26% up | ||
| 11 | Merck & CoMRK · Health Care | 1.08% | SEK 3.45T | SEK 1,399.21 | 4.00% down | 51% up | ||
| 12 | Abbott LaboratoriesABT · Health Care | 1.10% | SEK 1.84T | SEK 1,060.79 | 0.34% down | 17% down | ||
| 13 | BeOne MedicinesONC · Health Care | 1.40% | SEK 469.8B | SEK 4,112.70 | 2.10% down | 17% up | ||
| 14 | GenmabGMAB · Health Care | 1.57% | SEK 321.9B | SEK 522.11 | 1.15% down | 70% up | ||
| 15 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | SEK 1.39T | SEK 5,468.46 | 0.70% up | 27% up | ||
| 16 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | SEK 994B | SEK 9,608.25 | 1.32% down | 36% up | ||
| 17 | Royalty PharmaRPRX · Health Care | 2.27% | SEK 405.6B | SEK 705.45 | 1.04% up | 78% up | ||
| 18 | Bristol-Myers SquibbBMY · Health Care | 2.29% | SEK 1.24T | SEK 607.39 | 2.61% down | 34% up | ||
| 19 | PfizerPFE · Health Care | 2.36% | SEK 1.63T | SEK 285.34 | 1.41% down | 14% up | ||
| 20 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | SEK 500.1B | SEK 428.59 | 1.08% down | 74% up | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | SEK 127.2B | SEK 152.64 | 1.52% up | 5% up | ||
| 22 | ViatrisVTRS · Health Care | 3.07% | SEK 240B | SEK 209.31 | 0.68% up | 96% up | ||
| 23 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | SEK 77.5B | SEK 222.53 | 3.65% up | 83% up | ||
| 24 | Belite BioBLTE · Health Care | 3.40% | SEK 64.7B | SEK 1,593.02 | 0.64% down | 31% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | SEK 203.8B | SEK 1,521.51 | 4.36% down | 66% down | ||
| 26 | ZoetisZTS · Health Care | 4.12% | SEK 352.4B | SEK 867.24 | 2.19% up | 29% down | ||
| 27 | United TherapeuticsUTHR · Health Care | 4.31% | SEK 251.9B | SEK 5,914.07 | 0.40% down | 23% up | ||
| 28 | Ascendis PharmaASND · Health Care | 4.57% | SEK 180.3B | SEK 2,748.31 | 0.31% down | 28% up | ||
| 29 | ABIVAXABVX · Health Care | 4.70% | SEK 74.5B | SEK 850.47 | 1.90% up | 27% down | ||
| 30 | Summit TherapeuticsSMMT · Health Care | 5.28% | SEK 86.5B | SEK 108.11 | 0.33% down | 36% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | SEK 76B | SEK 966.86 | 0.00% | 126% up | ||
| 32 | Legend BiotechLEGN · Health Care | 6.13% | SEK 31.9B | SEK 164.38 | 0.37% up | 42% down | ||
| 33 | Axsome TherapeuticsAXSM · Health Care | 6.20% | SEK 71.9B | SEK 1,366.17 | 1.15% down | 7% down | ||
| 34 | Roivant SciencesROIV · Health Care | 6.28% | SEK 283.3B | SEK 390.97 | 0.65% down | 90% up | ||
| 35 | InsmedINSM · Health Care | 6.42% | SEK 268.5B | SEK 1,223.75 | 1.21% down | 40% down | ||
| 36 | Elanco Animal HealthELAN · Health Care | 6.59% | SEK 136.6B | SEK 273.31 | 4.00% up | 20% up | ||
| 37 | Definium TherapeuticsDFTX · Health Care | 7.02% | SEK 40B | SEK 291.96 | 2.25% down | 169% up | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | SEK 119.8B | SEK 618.48 | 3.98% up | 11% up | ||
| 39 | VeradermicsMANE · Health Care | 8.03% | SEK 53.4B | SEK 1,266.35 | 0.85% down | 233% up | ||
| 40 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | SEK 62B | SEK 438.45 | 0.33% up | 10% up | ||
| 41 | Corcept TherapeuticsCORT · Health Care | 8.34% | SEK 75.4B | SEK 689.24 | 3.24% down | 8% down | ||
| 42 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | SEK 160.8B | SEK 2,505.45 | 2.39% up | 37% up | ||
| 43 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | SEK 94.8B | SEK 4,082.26 | 4.84% down | 24% down | ||
| 44 | PTC TherapeuticsPTCT · Health Care | 9.31% | SEK 51.1B | SEK 611.06 | 0.41% down | 20% down | ||
| 45 | Oruka TherapeuticsORKA · Health Care | 9.53% | SEK 65.9B | SEK 971.03 | 0.83% down | 241% up | ||
| 46 | Travere TherapeuticsTVTX · Health Care | 9.96% | SEK 49.5B | SEK 515.86 | 0.69% down | 44% up | ||
| 47 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | SEK 61.2B | SEK 937.89 | 0.34% up | 31% up | ||
| 48 | Cogent BiosciencesCOGT · Health Care | 10.0% | SEK 49.7B | SEK 285.66 | 0.90% up | 20% down | ||
| 49 | ErascaERAS · Health Care | 10.6% | SEK 48.1B | SEK 137.03 | 2.95% down | 403% up | ||
| 50 | BridgeBio PharmaBBIO · Health Care | 10.7% | SEK 154.2B | SEK 791.76 | 1.41% up | 17% up | ||
| 51 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | SEK 46.3B | SEK 423.15 | 0.99% down | 88% up | ||
| 52 | AlkermesALKS · Health Care | 11.7% | SEK 79.5B | SEK 472.81 | 2.33% up | 58% up | ||
| 53 | Spyre TherapeuticsSYRE · Health Care | 12.2% | SEK 96.2B | SEK 1,012.61 | 6.18% up | 286% up | ||
| 54 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | SEK 61B | SEK 3,047.99 | 2.05% up | 43% up | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | SEK 46.9B | SEK 281.90 | 2.86% up | 64% down | ||
| 56 | CytokineticsCYTK · Health Care | 12.9% | SEK 72.4B | SEK 520.03 | 0.96% down | 20% down | ||
| 57 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | SEK 87.2B | SEK 3,118.24 | 0.55% up | 61% up | ||
| 58 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | SEK 83.3B | SEK 1,276.72 | 0.74% up | 46% up | ||
| 59 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | SEK 49.3B | SEK 874.66 | 1.08% down | 113% up | ||
| 60 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | SEK 85.2B | SEK 1,228.48 | 3.63% up | 13% up | ||
| 61 | TG TherapeuticsTGTX · Health Care | 19.0% | SEK 100.9B | SEK 667.63 | 4.73% up | 107% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1657 SEK).
Questions and answers
Which pharmaceutical companies have the lowest short interest?
Takeda Pharmaceutical (0.10%), AstraZeneca (0.20%) and Novartis (0.24%) have the lowest short interest of the 61 pharmaceutical companies ranked here as of the 30 Oct 2026 settlement date.
How many pharmaceutical companies are in this ranking?
61 are ranked by short interest.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by short interest have a combined market value of SEK 51.51T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceutical companies by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.